Simulation: the innovation gap in rare diseases

Bridging the scientific and economic challenges

Thursday, 28 September 2023 | 16:00-18:00 | Kursaal

Organised by Ipsen

The recent example of COVID-19 has demonstrated that innovative solutions are essential to healthcare systems and that political priorities impact drug development. This political will is particularly important for the 7,000+ rare and ultra-rare diseases, most of which have no approved treatments.  Yet the development of ‘orphan medicines’ is impeded by the limited scientific understanding and challenging economics of rare diseases.

This interactive session – involving a simulation, roundtable discussions followed by a panel discussion featuring key stakeholders - will shed light on the particularities of orphan drug development, how pharmaceutical companies make investment decisions, and the importance of an environment supportive of innovation to foster resilient health systems and ensure access for people with rare and ultra- rare diseases.

Session Recording

Speakers & panellists


Moderated by

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kurgartenstraße, 5630 Bad Hofgastein, Austria